These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 12239139)
1. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Honczarenko M; Le Y; Glodek AM; Majka M; Campbell JJ; Ratajczak MZ; Silberstein LE Blood; 2002 Oct; 100(7):2321-9. PubMed ID: 12239139 [TBL] [Abstract][Full Text] [Related]
2. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Hecht I; Cahalon L; Hershkoviz R; Lahat A; Franitza S; Lider O Int Immunol; 2003 Jan; 15(1):29-38. PubMed ID: 12502723 [TBL] [Abstract][Full Text] [Related]
3. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. D'Apuzzo M; Rolink A; Loetscher M; Hoxie JA; Clark-Lewis I; Melchers F; Baggiolini M; Moser B Eur J Immunol; 1997 Jul; 27(7):1788-93. PubMed ID: 9247593 [TBL] [Abstract][Full Text] [Related]
4. CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells. Basu S; Broxmeyer HE J Immunol; 2009 Dec; 183(11):7478-88. PubMed ID: 19917679 [TBL] [Abstract][Full Text] [Related]
5. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Ratajczak MZ; Majka M; Kucia M; Drukala J; Pietrzkowski Z; Peiper S; Janowska-Wieczorek A Stem Cells; 2003; 21(3):363-71. PubMed ID: 12743331 [TBL] [Abstract][Full Text] [Related]
6. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702 [TBL] [Abstract][Full Text] [Related]
7. CXCR4 and CCR5 expression by H9 T-cells is downregulated by a peptide-nucleic acid immunomodulator. Lazzarino DA; Diego M; Musi E; Hirschman SZ; Alexander RJ Immunol Lett; 2000 Nov; 74(3):189-95. PubMed ID: 11064099 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954 [TBL] [Abstract][Full Text] [Related]
9. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Kijowski J; Baj-Krzyworzeka M; Majka M; Reca R; Marquez LA; Christofidou-Solomidou M; Janowska-Wieczorek A; Ratajczak MZ Stem Cells; 2001; 19(5):453-66. PubMed ID: 11553854 [TBL] [Abstract][Full Text] [Related]
10. Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity. Van Drenth C; Jenkins A; Ledwich L; Ryan TC; Mashikian MV; Brazer W; Center DM; Cruikshank WW J Immunol; 2000 Dec; 165(11):6356-63. PubMed ID: 11086073 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1. Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220 [TBL] [Abstract][Full Text] [Related]
12. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines. Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155 [TBL] [Abstract][Full Text] [Related]
13. CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. Fernandis AZ; Cherla RP; Chernock RD; Ganju RK J Biol Chem; 2002 May; 277(20):18111-7. PubMed ID: 11877445 [TBL] [Abstract][Full Text] [Related]
14. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451 [TBL] [Abstract][Full Text] [Related]
15. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Reca R; Mastellos D; Majka M; Marquez L; Ratajczak J; Franchini S; Glodek A; Honczarenko M; Spruce LA; Janowska-Wieczorek A; Lambris JD; Ratajczak MZ Blood; 2003 May; 101(10):3784-93. PubMed ID: 12511407 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Lapidot T Ann N Y Acad Sci; 2001 Jun; 938():83-95. PubMed ID: 11458529 [TBL] [Abstract][Full Text] [Related]
17. Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1). Fedyk ER; Ryyan DH; Ritterman I; Springer TA J Leukoc Biol; 1999 Oct; 66(4):667-73. PubMed ID: 10534124 [TBL] [Abstract][Full Text] [Related]
18. I-TAC/CXCL11 is a natural antagonist for CCR5. Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708 [TBL] [Abstract][Full Text] [Related]
19. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Honczarenko M; Douglas RS; Mathias C; Lee B; Ratajczak MZ; Silberstein LE Blood; 1999 Nov; 94(9):2990-8. PubMed ID: 10556181 [TBL] [Abstract][Full Text] [Related]
20. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients. Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]